19
Page 1 of 19 SC028307_PRO_LTR_ENG State Approved 01142015 63822 © WellCare 2014 SC_11_14 July 13, 2015 Dear Provider: At the June 04, 2015 WellCare Pharmacy & Therapeutics Committee meeting, it was decided that the following changes will be made to the WellCare’s South Carolina Medicaid Preferred Drug List (PDL), effective August 15, 2015. Please carefully review these changes. Key UPPER CASE = Brand Name Drugs QL = Quantity Limit Lower case italics = Generic Drugs ST = Step Therapy PDL = Preferred Drug List AL = Age Limit PA = Prior Authorization YOA = Years of Age Effective date of change: August 15, 2015 Drug Name Therapeutic Class Change PDL Alternative (if applicable) ADDITIONS TO THE PDL acetaminophen 650 mg suppositories Analgesics - Nonnarcotic Added to the PDL aminophylline 25 mg/mL solution Antiasthmatic And Bronchodilator Agents Added to the PDL amphetamine- dextroamphetamine extended-release capsules - all strengths ADHD/Anti- Narcolepsy/Anti- Obesity/Anorexiants Added to the PDL w/ QL (62 capsules/31 days) & AL: Min 6 YOA, Max 20 YOA apap 325 mg tablets Analgesics - Nonnarcotic Added to the PDL argyle sterile 0.9% irrigation saline solution Genitourinary Agents - Miscellaneous Added to the PDL aspirin 81 mg enteric coated tablets Analgesics - Nonnarcotic Added to the PDL bismuth subsalicylate 262 mg/15 mL suspension Antidiarrheals Added to the PDL calcium Minerals & Added to the PDL UPDATE WellCare’s South Carolina Preferred Drug List

UPDATE WellCare’s South Carolina · © WellCare 2014 SC_11_14 July 13, 2015 Dear Provider: At the June 04, 2015 WellCare Pharmacy & Therapeutics Committee meeting, ... Agents Added

Embed Size (px)

Citation preview

Page 1 of 19

SC028307_PRO_LTR_ENG State Approved 01142015 63822 © WellCare 2014 SC_11_14

July 13, 2015

Dear Provider:

At the June 04, 2015 WellCare Pharmacy & Therapeutics Committee meeting, it was decided that the following changes will be made to the WellCare’s South Carolina Medicaid Preferred Drug List (PDL), effective August 15, 2015. Please carefully review these changes.

Key UPPER CASE = Brand Name Drugs QL = Quantity Limit

Lower case italics = Generic Drugs ST = Step Therapy

PDL = Preferred Drug List AL = Age Limit PA = Prior Authorization YOA = Years of Age

Effective date of change: August 15, 2015

Drug Name Therapeutic Class Change PDL Alternative

(if applicable)

ADDITIONS TO THE PDL

acetaminophen 650 mg suppositories

Analgesics - Nonnarcotic

Added to the PDL

aminophylline 25

mg/mL solution

Antiasthmatic And

Bronchodilator Agents

Added to the PDL

amphetamine-dextroamphetamine

extended-release capsules - all

strengths

ADHD/Anti-

Narcolepsy/Anti-Obesity/Anorexiants

Added to the PDL w/ QL (62

capsules/31 days) & AL: Min 6 YOA,

Max 20 YOA

apap 325 mg tablets Analgesics - Nonnarcotic

Added to the PDL

argyle sterile 0.9%

irrigation saline solution

Genitourinary

Agents - Miscellaneous

Added to the PDL

aspirin 81 mg enteric coated

tablets

Analgesics -

Nonnarcotic Added to the PDL

bismuth subsalicylate 262

mg/15 mL suspension

Antidiarrheals Added to the PDL

calcium Minerals & Added to the PDL

UPDATE WellCare’s South Carolina

Preferred Drug List

Page 2 of 19

SC028307_PRO_LTR_ENG State Approved 01142015 63822 © WellCare 2014 SC_11_14

carbonate/vitamin d 600 mg-400 unit

tablets

Electrolytes

Drug Name Therapeutic Class Change/Reason

for Change

PDL Alternative (if

applicable)

clozapine 12.5 mg orally disintegrating tablets

Antipsychotics/Antimanic Agents

Added to the PDL

w/ QL (31 tablets/31 days) &

AL: Min 18 YOA

delsym night time cough/cold 12.5-5 mg/5 mL liquid

Cough/Cold/Allergy Added to the PDL

delsym night time cough/cold 6.25-2.5 mg/5 mL liquid

Cough/Cold/Allergy Added to the PDL

DILANTIN 30 mg capsules

Anticonvulsants

Added to the PDL

w/ QL: 310 capsules/31 days

duloxetine 20 mg,

60 mg capsules Antidepressants

Added to the PDL

w/ QL (62 capsules/31 days) & ST (trial of

preferred SSRI, gabapentin,

amitriptyline, or venlafaxine).

duloxetine 30 mg

capsules Antidepressants

Added to the PDL w/ QL (31

capsules/31 days) & ST (trial of

preferred SSRI, gabapentin, amitriptyline, or

venlafaxine).

fentanyl 37.5 mcg, 62.5 mcg, 87.5 mcg

patches

Analgesics - Opioid Added to the PDL w/ PA & QL (10

patches/30 days)

IN-CHECK dial flow trainer device

Medical Devices Added to the PDL

KALYDECO 50 mg,

75 mg granules

Respiratory Agents -

Misc.

Added to the PDL

w/ PA

lidocaine-prilocaine 2.5-2.5% kit

Dermatologicals Added to the PDL

lithium carbonate Antipsychotics/Anti Added to the PDL

Page 3 of 19

SC028307_PRO_LTR_ENG State Approved 01142015 63822 © WellCare 2014 SC_11_14

150 mg, 600 mg capsules

manic Agents

Drug Name Therapeutic Class Change/Reason

for Change

PDL Alternative (if

applicable)

melatonin maximum strength 5 mg

tablets

Alternative

Medicines Added to the PDL

methylphenidate hydrochloride

chewable tablets - all strengths

ADHD/Anti-Narcolepsy/Anti-

Obesity/Anorexiants

Added to the PDL

w/ AL: Min 6 YOA

morphine sulfate

preservative free 2 mg/mL, 4 mg/mL injection

Analgesics - Opioid Added to the PDL

multivitamin/fluoride

0.25 mg chewable tablets

Multivitamins Added to the PDL

naproxen enteric

coated 500 mg tablets

Analgesics - Anti-

Inflammatory Added to the PDL

norethindrone & ethinyl estradiol-fe

0.8 mg-25 mcg chewable tablets

Contraceptives Added to the PDL

ONCASPAR 750 mg/mL injection

Antineoplastics and

Adjunctive Therapies

Added to the PDL w/ PA

oticin 1-0.1% otic

liquid Otic Agents Added to the PDL

oyster shell calcium/D 250 mg-125 unit tablets

Minerals & Electrolytes

Added to the PDL

phenytoin 50 mg chewable tablets

Anticonvulsants Added to the PDL w/ QL: 372 tablets/31 days

prenatal low iron 27-

0.8 mg tablets Multivitamins Added to the PDL

risperidone tablets -

all strengths

Antipsychotics/Anti

manic Agents

Added to the PDL w/ QL (62

tablets/31 days) & AL: Min 5 YOA

Drug Name Therapeutic Class Change/Reason

for Change

PDL Alternative (if

applicable)

Page 4 of 19

SC028307_PRO_LTR_ENG State Approved 01142015 63822 © WellCare 2014 SC_11_14

rizatriptan 5 mg, 10

mg tablets Migraine Products

Added to the PDL w/ AL: Min 6

YOA, Max 17 YOA

SANTYL 250

unit/gm ointment Dermatologicals Added to the PDL

slow release iron 160 (50 fe) mg

extended-release tablets

Hematopoietic

Agents Added to the PDL

tamoxifen 10 mg

tablets

Antineoplastics and Adjunctive

Therapies

Added to the PDL

trinate tablets Multivitamins Added to the PDL

vitamin b complex-c capsules

Multivitamins Added to the PDL

ZUBSOLV 8.6 mg-

2.1 mg sublingual tablets

Analgesics - Opioid Added to the PDL w/ PA

UTILIZATION MANAGEMENT CHANGES

ALKERAN 2 mg tablets

Antineoplastics and

Adjunctive Therapies

Added PA

butalbital-asa-

caffeine oral capsule 50-325-40

mg

Analgesics -

Nonnarcotic Removed QL

citalopram tablets -

all strengths Antidepressants Removed QL

dextroamphetamine extended-release

capsules - all strengths

ADHD/Anti-

Narcolepsy/Anti-Obesity/Anorexiants

Updated QL: 31

capsules/31 days

EMCYT 140 mg

capsules

Antineoplastics and

Adjunctive Therapies

Added PA

enoxaparin sodium injections - all

strengths

Anticoagulants

Updated QL: 300 mg/3 mL: QL: 93

mL/31 days 100 mg/mL: QL: 31 mL/31 days

150 mg/mL: QL: 31 mL/31 days 120 mg/0.8 mL: QL:

Page 5 of 19

SC028307_PRO_LTR_ENG State Approved 01142015 63822 © WellCare 2014 SC_11_14

24.8 mL/31 days 80 mg/0.8 mL: QL:

24.8 mL/31 days 30 mg/0.3 mL: QL: 9.3 mL/31 days

40 mg/0.4 mL: QL: 12.4 mL/31 days 60 mg/0.6 mL: QL:

18.6 mL/31 days

Drug Name Therapeutic Class Change/Reason

for Change

PDL Alternative (if

applicable)

etoposide 50 mg

capsules

Antineoplastics and

Adjunctive Therapies

Added PA

GABITRIL 12 mg,

16 mg tablets Anticonvulsants Removed AL

INVEGA SUSTENNA

injection

Antipsychotics/Antimanic Agents

Updated QL : 117 mg/0.75 mL: QL:

0.75 mL/28 days 156 mg/mL: QL: 1 mL/28 days

234 mg/1.5 mL: QL: 1.5 mL/28 days 39 mg/0.25 mL: QL:

0.25 mL/28 days 78 mg/0.5 mL: QL: 0.5 mL/28 days

LEUKERAN 2 mg tablets

Antineoplastics and

Adjunctive Therapies

Added PA

LOMUSTINE

capsules - all strengths

Antineoplastics and

Adjunctive Therapies

Added PA

loxapine 5 mg

capsules

Antipsychotics/Anti

manic Agents

Added AL: Min 18

YOA

LYSODREN 500 mg

tablets

Antineoplastics and Adjunctive

Therapies

Added PA

methylphenidate 10 mg extended-

release tablets

ADHD/Anti-Narcolepsy/Anti-

Obesity/Anorexiants

Added AL Max:

Max 20 YOA

methylphenidate tablets - all

strengths

ADHD/Anti-Narcolepsy/Anti-

Obesity/Anorexiants

Remove AL Max

MYLERAN 2 mg tablets

Antineoplastics and Adjunctive Therapies

Added PA

Page 6 of 19

SC028307_PRO_LTR_ENG State Approved 01142015 63822 © WellCare 2014 SC_11_14

nicotine polacrilex 2

mg, 4 mg mint gum

Psychotherapeutic And Neurological

Agents - Misc.

Updated QL: 2016 pieces/365

days

Drug Name Therapeutic Class Change/Reason

for Change

PDL Alternative (if

applicable)

oxcarbazepine 600 mg tablets

Anticonvulsants Removed QL

PEG-3350

ELECTROL 236 gm, 240 gm solution

Laxatives QL added: 4,000 mL/31 days

risperidone 1 mg/mL solution

Antipsychotics/Antimanic Agents

Updated QL &

Added AL: QL:496 mL/31 days, AL: Min 5

YOA

SAPHRIS 5 mg, 10 mg sublingual

tablets

Antipsychotics/Anti

manic agents

Updated AL: Min

10 YOA

spinosad 0.9% topical suspension

Dermatologicals Updated AL: Min 6 months of age

sumatriptan succinate 6 mg/0.5

mL solution for injection

Migraine Products Updated QL: 4

injections/31 days

TABLOID 40 mg

tablets

Antineoplastics and Adjunctive

Therapies

Added PA

thioridazine 100 mg

tablets

Antipsychotics/Anti

manic Agents

Added AL: Min 2

YOA

REMOVALS FROM THE PDL

ACETAMIN 80 mg/0.8 mL infant

drops

Analgesics -

Nonnarcotic

Removed from

PDL

Please reference PDL

acetasol hydrocortisone 2-1%

otic solution

Otic Agents Removed from PDL

Please reference PDL

ACIDOPHILUS PROBIOTIC tablets

Laxatives Removed from PDL

Please reference PDL

ACIDOPHILUS wafer

Laxatives Removed from PDL

Please reference PDL

Page 7 of 19

SC028307_PRO_LTR_ENG State Approved 01142015 63822 © WellCare 2014 SC_11_14

ACIDOPHILUS/BIFI

DUS wafer Laxatives

Removed from

PDL

Please reference PDL

Acidophilus/Pectin

capsules Laxatives

Removed from

PDL

Please reference PDL

acitretin 17.5 mg

capsules Dermatologicals

Removed from

PDL

Please reference PDL

acne wash 2 %

liquid Dermatologicals

Removed from

PDL

Please reference PDL

ADDERALL XR capsules - all strengths

ADHD/Anti-Narcolepsy/Anti-Obesity/Anorexiants

Removed from PDL

amphetamine/dextroamphetamine

extended-release capsules - all

strengths (QL, AL may apply)

ADRUCIL 500

mg/10mL injection

Antineoplastics and

Adjunctive Therapies

Removed from

PDL

fluorouracil 500

mg/10ml solution

AFRIN 0.05% nasal

spray solution

Nasal Agents - Systemic And

Topical

Removed from

PDL

Please reference PDL

ALTARYL 12.5 mg/5

mL syrup Antihistamines

Removed from

PDL

Please reference PDL

AMITIZA 8 mcg, 24

mcg capsules

Gastrointestinal

Agents - Misc.

Removed from

PDL

lactulose oral solution;

polyethylene glycol

antifungal 1 %

aerosol Dermatologicals

Removed from

PDL

Please reference PDL

artificial tears 83-15

% ophthalmic ointment

Ophthalmic Agents Removed from

PDL

Please reference PDL

artificial tears 0.1-0.3 % ophthalmic

solution

Ophthalmic Agents Removed from

PDL

Please reference PDL

b complex 50 tablets Multivitamins Removed from PDL

Please reference PDL

baby d-drops 400 unit/0.03 mL liquid

Vitamins Removed from PDL

Please reference PDL

Page 8 of 19

SC028307_PRO_LTR_ENG State Approved 01142015 63822 © WellCare 2014 SC_11_14

benzoyl peroxide 10%, 5% liquid

wash

Dermatologicals Removed from

PDL Please reference PDL

benzoyl peroxide 6

% cleanser lotion Dermatologicals

Removed from

PDL Please reference PDL

beta care cream,

lotion Dermatologicals

Removed from

PDL Please reference PDL

BP 10-1% emulsion Dermatologicals Removed from

PDL Please reference PDL

BP 2.5 % liquid

wash Dermatologicals

Removed from

PDL Please reference PDL

BP 4 % cleansing

lotion Dermatologicals

Removed from

PDL

Please reference PDL

calamine 8-8 %

lotion Dermatologicals

Removed from

PDL

Please reference PDL

calamine lotion Dermatologicals Removed from

PDL

Please reference PDL

calamine

phenolated lotion Dermatologicals

Removed from

PDL

Please reference PDL

calcitrate 315-250

mg-unit tablets

Minerals &

Electrolytes

Removed from

PDL

Please reference PDL

calcitriol 3 mcg/gm

ointment Dermatologicals

Removed from

PDL

Please reference PDL

calcium 1200-1200-1000 mg-unit

chewable tablets

Minerals &

Electrolytes

Removed from

PDL

Please reference PDL

calcium 500 + d 500-125 mg-unit

tablets

Minerals & Electrolytes

Removed from PDL

Please reference PDL

calcium 600 + minerals 600-200 mg-unit tablets

Minerals & Electrolytes

Removed from PDL

Please reference PDL

calcium 600+d 600-200 mg-unit tablets

Minerals & Electrolytes

Removed from PDL

Please reference PDL

calcium 600+d plus minerals 600-400 mg-unit chewable

tablets

Minerals & Electrolytes

Removed from PDL

Please reference PDL

Page 9 of 19

SC028307_PRO_LTR_ENG State Approved 01142015 63822 © WellCare 2014 SC_11_14

calcium 600+d plus minerals 600-400

mg-unit tablets

Minerals &

Electrolytes

Removed from

PDL

Please reference PDL

calcium 600-1500

mg tablets

Minerals &

Electrolytes

Removed from

PDL

Please reference PDL

calcium citrate 200

mg tablets

Minerals &

Electrolytes

Removed from

PDL

Please reference PDL

calcium-carbonate 600 + d 600-125

mg-unit tablets

Minerals &

Electrolytes

Removed from

PDL

Please reference PDL

calcium-magnesium-zinc 333-133-5 mg

tablets

Minerals & Electrolytes

Removed from PDL

Please reference PDL

calcium-vitamin d 600-200 mg-unit tablets

Minerals & Electrolytes

Removed from PDL

Please reference PDL

cetaphil liquid Dermatologicals Removed from PDL

Please reference PDL

chewable calcium 500-200-40 mg-unt-mcg chewable

tablets

Minerals & Electrolytes

Removed from PDL

Please reference PDL

children's complete allergy 12.5 mg

chewable tablets

Antihistamines Removed from PDL

Please reference PDL

childrens silfedrine 15 mg/5mL liquid

Nasal Agents - Systemic And Topical

Removed from PDL

Please reference PDL

citranatal dha 27-1 & 250 mg pak

Multivitamins Removed from PDL

Please reference PDL

citranatal rx 27-1 mg tablets

Multivitamins Removed from PDL

Please reference PDL

clemastine fumarate 0.67 mg/5 mL syrup

Antihistamines Removed from PDL

Please reference PDL

colloidal oatmeal bath packet

Dermatologicals Removed from PDL

Please reference PDL

complete natal dha

29-1-200 & 250 mg pak

Multivitamins Removed from PDL

Please reference PDL

Page 10 of 19

SC028307_PRO_LTR_ENG State Approved 01142015 63822 © WellCare 2014 SC_11_14

condoms Medical Devices Removed from

PDL Please reference PDL

COPEGUS 200 mg tablets

Antivirals Removed from PDL

Hepatitis C drugs are now covered

by the state. Refer to Fee For

Service PDL for specifics

CORDRAN 4

mcg/sqcm tape Dermatologicals

Removed from

PDL Please reference PDL

dermaphor ointment Dermatologicals Removed from

PDL

Please reference PDL

dexamethasone

sodium phosphate preservative free 10

mg/mL injection

Corticosteroids Removed from PDL

dexamethasone

sodium phosphate injection

solution 10 mg/ml

DIFF-STAT chewables

Laxatives Removed from PDL

Please reference PDL

diltiazem

hydrochloride 100 mg reconstituted solution intravenous

Calcium Channel Blockers

Removed from PDL

diltiazem hcl intravenous

solution 125 mg/25ml, 25 mg/5ml, 50

mg/10ml

diphenhydramine

12.5 mg/5 mL elixir Antihistamines

Removed from

PDL Please reference PDL

domeboro packet Dermatologicals Removed from

PDL Please reference PDL

doxycycline monohydrate 100

mg tablets

Tetracyclines Removed from PDL

doxycycline monohydrate 100

mg capsules

ENDOMETRIN 100 mg suppositories

Vaginal Products Removed from PDL

progesterone 100 mg capsules

etoposide 500 mg/25 mL injection

Antineoplastics and Adjunctive Therapies

Removed from PDL

EURAX 10% cream, lotion

Dermatologicals Removed from PDL

permethrin external lotion 1 %; permethrin

Page 11 of 19

SC028307_PRO_LTR_ENG State Approved 01142015 63822 © WellCare 2014 SC_11_14

external cream 5 %

exemestane 25 mg

tablets

Antineoplastics and Adjunctive

Therapies

Removed from

PDL

anastrozole oral

tablet

eye drops advanced relief 0.05-0.1-1-1 %

ophthalmic solution

Ophthalmic Agents Removed from

PDL

Please reference PDL

fareston 60 mg tablets

Antineoplastics and Adjunctive

Therapies

Removed from PDL

tamoxifen 10 mg tablets

FIBER THERAPY 500 mg tablets

Laxatives Removed from PDL

Please reference PDL

FLORANEX chewables

Laxatives Removed from PDL

Please reference PDL

flutamide 125 mg capsules

Antineoplastics and Adjunctive Therapies

Removed from PDL

FORMULA EM 1.87-1.87-21.5 solution

Antiemetics Removed from PDL

Please reference PDL

GAVILYTE-C SOL 60/15 mL stool softener syrup

Laxatives Removed from PDL

Please reference PDL

GENERESS FE chewable tablets

Contraceptives Removed from PDL

norethindrone &

ethinyl estradiol-fe 0.8 mg-25 mcg

chewable tablets

genteal 0.25-0.3 % ophthalmic gel

Ophthalmic Agents Removed from PDL

Please reference PDL

genteal mild 0.2 % ophthalmic solution

Ophthalmic Agents Removed from PDL

Please reference PDL

genteal mild to moderate 0.3 % ophthalmic solution

Ophthalmic Agents Removed from PDL

Please reference PDL

genteal severe 0.3 % ophthalmic gel

Ophthalmic Agents Removed from PDL

Please reference PDL

glycerin 2 gm, 2.1 gm suppositories

Laxatives Removed from PDL

Please reference PDL

Page 12 of 19

SC028307_PRO_LTR_ENG State Approved 01142015 63822 © WellCare 2014 SC_11_14

glycerin liquid Dermatologicals Removed from

PDL Please reference PDL

GNP capsaicin 0.1

% cream Dermatologicals

Removed from

PDL

Please reference PDL

goniovisc 2.5 %

ophthalmic solution Ophthalmic Agents

Removed from

PDL Please reference PDL

haloperidol 20 mg

tablets

Antipsychotics/Anti

manic Agents

Removed from

PDL

haloperidol oral

tablet 10 mg

HARVONI 90-400 mg tablets

Antivirals Removed from PDL

Hepatitis C drugs are now covered

by the state. Refer to Fee For

Service PDL for specifics

hemorrhoidal 0.25-

3-14-71.9 % ointment

Anorectal Agents Removed from

PDL

Please reference PDL

hemorrhoidal 0.25-3-85.5 %

suppository

Anorectal Agents Removed from

PDL

Please reference PDL

homatropine hydrobromide 5 %

ophthalmic solution

Ophthalmic Agents Removed from PDL

atropine sulfate ophthalmic

solution

hydrocortisone-aloe 0.5%, 1% cream

Dermatologicals Removed from PDL

Please reference PDL

INCIVEK 375 mg tablets

Antivirals Removed from PDL

Hepatitis C drugs are now covered

by the state. Refer to Fee For Service PDL for

specifics

INFERGEN

injections - all strengths

Antivirals Removed from PDL

Hepatitis C drugs are now covered

by the state. Refer to Fee For Service PDL for

specifics

INSPIREASE bags, mouthpiece

Medical Devices Removed from PDL

Please reference PDL

Page 13 of 19

SC028307_PRO_LTR_ENG State Approved 01142015 63822 © WellCare 2014 SC_11_14

invisible acne treatment 10 %

cream

Dermatologicals Removed from

PDL

Please reference PDL

KALA tablets Laxatives Removed from

PDL

Please reference PDL

KLOR-CON 20 meq,

25 meq packets

Minerals &

Electrolytes

Removed from

PDL

KLOR-CON oral

tablets; potassium

chloride oral

solution 20meq/15ml (10%)

lactobacillus tablets, packets, wafers

Antidiarrheals Removed from PDL

Please reference PDL

LAXATIVE

W/SENNA 25 mg tablets

Laxatives Removed from PDL

Please reference PDL

leuprolide 1 mg/0.2 mL injection

Antineoplastics and

Adjunctive Therapies

Removed from PDL

LICE KILLING

maximum strength 0.33-4% shampoo

Dermatologicals Removed from

PDL

spinosad 0.9%

topical suspension

lice treatment 0.33-4

% liquid Dermatologicals

Removed from

PDL

spinosad 0.9% topical

suspension

lice treatment 1 %

liquid Dermatologicals

Removed from

PDL

spinosad 0.9% topical

suspension

loperamide-simethicone 2-125

mg tablets

Antidiarrheals Removed from PDL

Please reference PDL

lubricant eye drops 0.4-0.3 % ophthalmic solution

Ophthalmic Agents Removed from PDL

Please reference PDL

lubricating plus eye

drops 0.5 % ophthalmic solution

Ophthalmic Agents Removed from PDL

Please reference PDL

LUPRON-DEPOT

injection - all strengths

Antineoplastics and

Adjunctive Therapies

Removed from PDL

TRELSTAR suspension

magnesium citrate

1.745 gm/30mL solution

Laxatives Removed from

PDL Please reference PDL

Page 14 of 19

SC028307_PRO_LTR_ENG State Approved 01142015 63822 © WellCare 2014 SC_11_14

methyldopate hydrochloride 250

mg/5 mL solution

Antihypertensives Removed from

PDL

METHYLIN

chewable tablets - all strengths

ADHD/Anti-

Narcolepsy/Anti-Obesity/Anorexiants

Removed from

PDL

methylphenidate hcl chewable tabs

- all strengths (AL may apply)

metronidazole 0.75

% gel Dermatologicals

Removed from

PDL

metronidazole

external 1 %

MINERAL OIL

ENEMA Laxatives

Removed from

PDL Please reference PDL

MODERIBA pak - all strengths

Antivirals Removed from PDL

Hepatitis C drugs

are now covered by the state. Refer to Fee For

Service PDL for specifics

muscle relief 0.075 % cream

Dermatologicals Removed from PDL

Please reference PDL

naproxen sodium

220 mg tablets

Analgesics - Anti-

Inflammatory

Removed from

PDL

naproxen oral

tablet 250 mg, 375 mg, 500 mg

nasal decongestant

10 mg tablets

Nasal Agents -

Systemic And Topical

Removed from

PDL Please reference PDL

natures tears 0.4 %

ophthalmic solution Ophthalmic Agents

Removed from

PDL Please reference PDL

NATURL FIBER

68% powder Laxatives

Removed from

PDL Please reference PDL

NIACIN er 250 mg extended-release

tablets

Vitamins Removed from

PDL

no flush niacin

oral tablet 500 mg

NORDITROPIN flexpro solution - all

strengths

Endocrine And Metabolic Agents -

Misc.

Removed from

PDL

OMNITROPE subcutaneous

solution (PA applies)

OLYSIO 150 mg capsules

Antivirals Removed from PDL

Hepatitis C drugs are now covered

by the state. Refer to Fee For

Service PDL for specifics

Page 15 of 19

SC028307_PRO_LTR_ENG State Approved 01142015 63822 © WellCare 2014 SC_11_14

ORAL SALINE

laxative solution Laxatives

Removed from

PDL Please reference PDL

oyst-cal d 250-125

mg-unit tablets

Minerals &

Electrolytes

Removed from

PDL Please reference PDL

oyster shell calcium +D 500 mg-400U

tablets

Minerals &

Electrolytes

Removed from

PDL Please reference PDL

oyster shell calcium 250+d 250-125 mg-

unit tablets

Minerals &

Electrolytes

Removed from

PDL Please reference PDL

oyster shell calcium/d 500-200

mgunit tablets

Minerals & Electrolytes

Removed from PDL

Please reference PDL

PAIN & FEVER 80 mg chewables

Analgesics - Nonnarcotic

Removed from PDL

Please reference PDL

parva-cal 500-200 mg-unit tablets

Minerals & Electrolytes

Removed from PDL

Please reference PDL

PEDIA-LAX 1 gm suppositories

Laxatives Removed from PDL

Please reference PDL

PEGASYS kit,

injection, proclick Antivirals

Removed from

PDL

Hepatitis C drugs are now covered by the state.

Refer to Fee For Service PDL for

specifics

PEG-INTRON kit - all strengths

Antivirals Removed from PDL

Hepatitis C drugs are now covered

by the state. Refer to Fee For Service PDL for

specifics

phenazo 95 mg tablets

Genitourinary Agents -

Miscellaneous

Removed from PDL

phenazopyridine hcl oral tablet 100

mg, 200 mg

polyvitamin/iron chewable tablets

Multivitamins Removed from PDL

Please reference PDL

potassium bicarbonate 25 meq

effervescent tablets

Minerals &

Electrolytes

Removed from

PDL

potassium chloride crys er oral tablet

extendedrelease 10 meq, 20 meq

Page 16 of 19

SC028307_PRO_LTR_ENG State Approved 01142015 63822 © WellCare 2014 SC_11_14

potassium citrate 5 meq (540 mg)

extended-release tablets

Genitourinary

Agents - Miscellaneous

Removed from

PDL

cytra-2 oral

solution

pr natal 400 29-1-200 & 400 mg pak

Multivitamins Removed from PDL

Please reference PDL

pr natal 430 29-1-200 & 430 mg pak

Multivitamins Removed from PDL

Please reference PDL

pr natal 430 ec 29-

1-200 & 430 mg (dr) pak

Multivitamins Removed from PDL

Please reference PDL

PROBIOTIC DAILY

capsules Laxatives

Removed from

PDL

Please reference PDL

promethazine 25

mg/mL injection Antihistamines

Removed from

PDL

promethazine

hydrochloride 50 mg/mL solution injection

Antihistamines Removed from PDL

PROMETHEGAN SUPPOSITORY 12.5

MG Antihistamines

Removed from PDL

promethazine hcl

suppository 25 mg

PSYLDEX 30% powder

Laxatives Removed from PDL

Please reference PDL

pyrethins-piperonyl

butoxide 0.2-2 % liquid

Dermatologicals Removed from PDL

Please reference PDL

QC NATURAL

VEGETABLE powder

Laxatives Removed from

PDL

Please reference PDL

RA aspirin 500 mg

tablets

Analgesics -

Nonnarcotic

Removed from

PDL

Please reference PDL

RA COL-RITE

50MG capsules Laxatives

Removed from

PDL

Please reference PDL

ra hemorrhoidal 0.25-3-12-18 %

cream

Anorectal Agents Removed from

PDL

Please reference PDL

REBETOL • 40 mg/mL solution

• 200 mg capsules

Antivirals Removed from PDL

Hepatitis C drugs are now covered

by the state.

Page 17 of 19

SC028307_PRO_LTR_ENG State Approved 01142015 63822 © WellCare 2014 SC_11_14

Refer to Fee For Service PDL for

specifics

REBETRON kit - all strengths

Antivirals Removed from PDL

Hepatitis C drugs are now covered

by the state. Refer to Fee For

Service PDL for specifics

REGONOL 5 mg/mL

injection

Antimyasthenic/Chol

inergic Agents

Removed from

PDL

renal 1 mg

capsules Multivitamins

Removed from

PDL Please reference PDL

ribavirin 500 mg tablets

Antivirals Removed from PDL

Hepatitis C drugs are now covered

by the state. Refer to Fee For

Service PDL for specifics

salivasure mouth/throat

lozenges

Mouth/Throat/Dental

Agents

Removed from

PDL Please reference PDL

SB FIB LAX 33%

powder Laxatives

Removed from

PDL Please reference PDL

sb lice treatment

0.3-3 % liquid Dermatologicals

Removed from

PDL

spinosad 0.9% topical

suspension

select-ob 29-1 mg chewable tablets

Multivitamins Removed from PDL

Please reference PDL

sf 5000 plus 1.1 % dental cream

Mouth/Throat/Dental Agents

Removed from PDL

PHOS-FLUR DENTAL 1.1 %

sirolimus 1 mg, 2 mg tablets

Assorted Classes Removed from PDL

tacrolimus oral capsule 0.5 mg, 1

mg, 5 mg

sm ibuprofen 100 mg junior tablets, chewables

Analgesics - Anti-Inflammatory

Removed from PDL

Please reference PDL

SMOOTH LAX 3350 NF powder packets

Laxatives Removed from PDL

Please reference PDL

Page 18 of 19

SC028307_PRO_LTR_ENG State Approved 01142015 63822 © WellCare 2014 SC_11_14

sodium chloride (hypertonic) 5%

ophthalmic solution

Ophthalmic Agents Removed from

PDL Please reference PDL

SOVALDI 400 mg tablets

Antivirals Removed from PDL

Hepatitis C drugs are now covered

by the state. Refer to Fee For

Service PDL for specifics

SUDAFED-12 12 hr* 120 mg

extended-release tablets

Nasal Agents -

Systemic And Topical

Removed from

PDL

Please reference PDL

sulfacetamide

sodium- sulfur 10-5% cream, lotion

Dermatologicals Removed from

PDL

sulfacetamide

sodium external suspension 10 %

tears again

ophthalmic ointment Ophthalmic Agents

Removed from

PDL Please reference PDL

tolnaftate 1 %

solution Dermatologicals

Removed from

PDL Please reference PDL

TUCKS 51%

suppository Anorectal Agents

Removed from

PDL Please reference PDL

UNIVERT 32 mg

tablets Antiemetics

Removed from

PDL Please reference PDL

verapamil

hydrochloride 2.5 mg/mL solution injection

Calcium Channel Blockers

Removed from PDL

VICTRELIS 200 mg

capsules Antivirals

Removed from

PDL

Hepatitis C drugs

are now covered by the state.

Refer to Fee For Service PDL for specifics

VIEKIRA pak tablets Antivirals Removed from

PDL

Hepatitis C drugs

are now covered by the state.

Refer to Fee For Service PDL for specifics

vitamin a 10,000 unit tablets

Vitamins Removed from PDL

Please reference PDL

Page 19 of 19

SC028307_PRO_LTR_ENG State Approved 01142015 63822 © WellCare 2014 SC_11_14

vitamin a 25,000

unit capsules Vitamins

Removed from

PDL Please reference PDL

vitamin a palmitate

15,000 unit tablets Vitamins

Removed from

PDL Please reference PDL

vitamin c 500 mg extended-release

tablets

Vitamins Removed from

PDL Please reference PDL

vitamin c 500

mg/5mL liquid Vitamins

Removed from

PDL Please reference PDL

vitamin c tablet 1000

MG ORAL; vitamin c

tablet 100 MG

Vitamins Removed from

PDL

Please reference PDL

vitamin D 400 unit capsules

Vitamins Removed from PDL

Please reference PDL

vitamin d3 2,000 unit super strength

tablets

Vitamins Removed from PDL

Please reference PDL

vitamin d3 50,000 unit capsules

Vitamins Removed from PDL

Please reference PDL

vitatrum chewable tablets

Multivitamins Removed from PDL

Please reference PDL

zinc 25 mg tablets Minerals & Electrolytes

Removed from PDL

Please reference PDL

ZYTIGA 250 mg tablets

Antineoplastics and Adjunctive Therapies

Removed from PDL

If you have questions, WellCare’s Pharmacy Help Desk and its affiliated vendor, Catamaran, are available to assist providers at 1-888-588-9842.

Thank you for your care of WellCare’s South Carolina Medicaid members. Sincerely,

WellCare Health Plans, Inc.